FinTechFunding

Mayne Pharma: Appoints former AstraZeneca leader as new CEO

Mayne Pharma Appoints former AstraZeneca leader as new CEO

  • Mayne Pharma (MYX) appoints Shawn Patrick O’Brien as its new CEO and Managing Director
  • Following the retirement of Scott Richards, announced last month, Mr O’Brien will take the reigns on October 1
  • MYX says with over 35 years of experience in the global pharmaceutical industry, including 17 years at AstraZeneca, the new CEO is an “ideal choice” to lead the company
  • The company says Mr O’Brien has “a proven ability” to turn around organisations, lead large and diverse teams, and deliver growth within both public and private companies
  • MYX shares are up 4.9 per cent trading at 27 cents at 1:36 pm AEST
Previous article
Checkmate: Lands $5m seed funding
Next article
Spacetalk: Officially launches JumpySIM in Australia
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

Regulators Strengthen Global Crackdown on Finfluencers

A new collaborative approach targets financial influencers amid rising concerns.Highlights: Financial regulators unite to control finfluencers' market impact.Concerns...
FinTech

ECB Strengthens Digital Euro Rollout with Standard Setter Agreements

New collaborations aim to facilitate the digital euro's global integration.Highlights: ECB partners with key global standard setters.Agreements aim...
FinTech

CreditNature Strengthens Nature Restoration Funding Through Everyday Transactions

New partnership enables businesses to support environmental initiatives seamlessly.Highlights: CreditNature teams up with Stabiliti for eco-friendly funding.Businesses can...
FinTech

FedNow Strengthens Instant Payments Security with New API Tool

New API tool enhances security for immediate digital transactions in the U.S.Highlights: FedNow introduces a new API tool...